Results 11 to 20 of about 205,027 (361)

[Age-related macular degeneration]. [PDF]

open access: yesNew England Journal of Medicine, 2006
Hægt er að lesa greinina í heild sinni með því að smella á hlekkinn View/OpenAge-related macular degeneration (AMD) is the main reason for blindness today in the western hemisphere.
A. Ramé
semanticscholar   +9 more sources

Investigating the modulation of genetic effects on late AMD by age and sex: Lessons learned and two additional loci. [PDF]

open access: yesPLoS ONE, 2018
Late-stage age-related macular degeneration (AMD) is the leading cause of visual impairment in the elderly with a complex etiology. The most important non-modifiable risk factors for onset and progression of late AMD are age and genetic risk factors ...
Thomas W Winkler   +8 more
doaj   +4 more sources

Age-related macular degeneration

open access: yesClinical Ophthalmology, 2011
Giuseppe Querques¹, Fernando Onofrio Avellis1,2, Lea Querques1,3, Francesco Bandello³, Eric H Souied¹ ¹Service d'Ophtalmologie, Centre Hospitalier Intercommunal Créteil, Université Paris ...
Querques G   +4 more
doaj   +4 more sources

Metabolomics and Age-Related Macular Degeneration [PDF]

open access: yesMetabolites, 2018
Age-related macular degeneration (AMD) leads to irreversible visual loss, therefore, early intervention is desirable, but due to its multifactorial nature, diagnosis of early disease might be challenging.
Connor N. Brown   +5 more
doaj   +7 more sources

Age-Related Macular or Retinal Degeneration?

open access: yesMedicina, 2023
Age-related macular degeneration (AMD) is an eye disease that leads to progressive vision loss. Its prevalence has been increasing due to population aging.
Michalina Gałuszka   +2 more
doaj   +3 more sources

Age-related macular degeneration

open access: yesCommunity Eye Health Journal, 2014
Age-related macular degeneration (AMD) is a disease of the retina that usually develops in people aged 60 years and older. It affects about 8.7% of the world’s population and is the leading cause of blindness among people aged 50 and older in ...
Wanjiku Mathenge
doaj   +3 more sources

Nanotechnology for Age-Related Macular Degeneration [PDF]

open access: yesPharmaceutics, 2021
Age-related macular degeneration (AMD) is a degenerative eye disease that is the leading cause of irreversible vision loss in people 50 years and older.
Bo Yang   +6 more
doaj   +4 more sources

Age-related macular degeneration [PDF]

open access: yesNature Reviews Disease Primers, 2021
Age-related macular degeneration (AMD) is the leading cause of legal blindness in the industrialized world. AMD is characterized by accumulation of extracellular deposits, namely drusen, along with progressive degeneration of photoreceptors and adjacent tissues.
Monika Fleckenstein   +7 more
  +10 more sources

Pharmacogenetics and Age-Related Macular Degeneration [PDF]

open access: yesJournal of Ophthalmology, 2011
Pharmacogenetics seeks to explain interpatient variability in response to medications by investigating genotype-phenotype correlations. There is a small but growing body of data regarding the pharmacogenetics of both nonexudative and exudative age ...
Stephen G. Schwartz, Milam A. Brantley
doaj   +3 more sources

Choriocapillaris in Age-Related Macular Degeneration

open access: yesTürk Oftalmoloji Dergisi
Age-related macular degeneration (AMD) is a multifactorial disease characterized by progressive alterations of different retinal structures ultimately leading to vision loss.
Giovanni Neri   +6 more
doaj   +4 more sources

Home - About - Disclaimer - Privacy